| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 20,498 | 20,656 | 21,039 | 20,856 | | Cost of Revenue | 6,087 | 6,549 | 6,501 | 5,802 | | | Gross Profit | 14,411 | 14,107 | 14,538 | 15,054 | | | Operating Expenses | | Research Development | 1,859 | 1,613 | 1,774 | 2,005 | | Selling General and Administrative | 10,492 | 10,381 | 9,883 | 9,623 | | Non Recurring |
-
|
-
|
-
| 4,246 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,060 | 2,113 | 2,881 | (820) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 341 | (6,443) | 180 | 185 | | Earnings Before Interest And Taxes | 2,402 | (4,330) | 3,061 | (635) | | Interest Expense | 494 | 534 | 1,585 | 3,901 | | Income Before Tax | 1,908 | (4,864) | 1,476 | (4,536) | | Income Tax Expense | 544 | (1,616) | 240 | 299 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,364 | (3,247) | 1,236 | (4,835) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,364 | (3,247) | 1,236 | (4,835) | | Preferred Stock And Other Adjustments | (216) | (184) | (49) | (50) | | | Net Income Applicable To Common Shares | $1,148 | ($3,431) | $1,187 | ($4,886) |
|
0.56% Nasdaq 
Income Statement
